Genes News and Research

RSS

Exploring the interactions between multiple respiratory viruses

A recent report explores the dynamics of viral interference between various respiratory viruses in light of the ongoing COVID-19 pandemic.

19 Jan 2022

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

A new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has identified a new potential pathway for developing therapeutics that target Epstein-Barr virus (EBV).

19 Jan 2022

Yale research sheds light on the lifespan and myriad functions of messenger RNAs

It took a global pandemic, but the critical role of messenger RNA in all of life's functions has taken center stage in the past year with the successful rollout of mRNA vaccines to combat the SARS-Cov-2 virus.

19 Jan 2022

Non-invasive, novel urinary miRNA biomarker panel for colorectal cancer diagnosis

Researchers set out to develop and validate urine biomarkers for diagnosing gastric cancer and colorectal cancer.

19 Jan 2022

Exploring biological characteristics of SARS-CoV-2-induced myocardial damage

In a new study, researchers used bioinformatics tools to explore the biological characteristics of SARS-CoV-2-infected myocardium.

19 Jan 2022

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

A new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators was used to diagnose rare genetic diseases in an average of eight hours — a feat that's nearly unheard of in standard clinical care.

19 Jan 2022

Impact of COVID-19 on male and female reproductive health

A new review article investigated the relation between SARS-CoV-2 infection and reproductive health.

19 Jan 2022

New method reverses insecticide resistance using CRISPR/Cas9 technology

Insecticides play a central role in efforts to counter global impacts of mosquito-spread malaria and other diseases, which cause an estimated 750,000 deaths each year. These insect-specific chemicals, which cost more than $100 million to develop and bring to market, also are critical to controlling insect-driven damage on crops that poses a challenge to food security.

18 Jan 2022

Macrodomains represent a unique target for pathogens with pandemic potential

In a new study published in the journal Pathogens, researchers have summarized the role of the macrodomain in viral replication and virulence and further reviewed the development of macrodomain inhibitors as antiviral agents.

18 Jan 2022

Machine learning model identifies new risk genes for motor neurone disease

Scientists have developed a new machine learning model for the discovery of genetic risk factors for diseases such as Motor Neurone Disease (MND).

18 Jan 2022

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

The University of Texas MD Anderson Cancer Center and Eisbach Bio GmbH today announced a strategic research collaboration to jointly discover and develop precision oncology drugs that target synthetic lethal engines key to tumor genome evolution.

18 Jan 2022

Rare genetic variants may raise risk of fatal arrhythmias in patients with less advanced coronary artery disease

Advanced coronary artery disease and the cardiac hypertrophy often associated with it is the most common cause of sudden cardiac death.

18 Jan 2022

Research provides new insights on memory loss in Alzheimer's disease

Members of the "Synaptic Dysfunction and Disease" group at the Institute of Biomedicine of Seville, led by researchers Francisco Gómez Scholl and Amalia Martínez Mir, recently published the results of their research into Alzheimer's disease.

18 Jan 2022

New pathways responsible for hepatocellular carcinoma identified

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It is one of leading causes of cancer-related deaths globally, with more than 700,000 new cases and 600,000 estimated HCC deaths each year.

18 Jan 2022

Respiratory viruses lacking NS2 protein can be destroyed by the body's immune response

One viral protein could provide information to deter pneumonia causing the body's exaggerated inflammatory response to respiratory viruses, including the virus that causes COVID-19.

18 Jan 2022

Direct effect of SARS-CoV-2 on the kidney

Researchers infected human-induced pluripotent-stem-cell (iPSC)-derived kidney organoids with SARS-CoV-2 to study the virus's direct effect on the kidney.

18 Jan 2022

UniSA scientists make a surprising discovery in the origins of antibiotic-resistant gene

University of South Australia scientists have made a surprising discovery in the origins of an antibiotic-resistant gene previously thought to have been confined to Adelaide.

18 Jan 2022

Researchers report isolation of potently neutralizing antibodies against highly transmissible SARS-CoV-2 variants

A recent preprint discusses using a combinatorial phage-display library approach to COVIID-19 antibodies.

18 Jan 2022

DPP4 protein: The connection between severe COVID-19 and diabetes

Researchers explore the relationship between DPP4 and diabetes targets in the management of COVID-19.

17 Jan 2022

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

Researchers determine the driving factors for disease severity and death due to COVID-19.

17 Jan 2022

Genes News and Research

Exploring the interactions between multiple respiratory viruses

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

Yale research sheds light on the lifespan and myriad functions of messenger RNAs

Non-invasive, novel urinary miRNA biomarker panel for colorectal cancer diagnosis

Exploring biological characteristics of SARS-CoV-2-induced myocardial damage

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

Impact of COVID-19 on male and female reproductive health

New method reverses insecticide resistance using CRISPR/Cas9 technology

Macrodomains represent a unique target for pathogens with pandemic potential

Machine learning model identifies new risk genes for motor neurone disease

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

Rare genetic variants may raise risk of fatal arrhythmias in patients with less advanced coronary artery disease

Research provides new insights on memory loss in Alzheimer's disease

New pathways responsible for hepatocellular carcinoma identified

Respiratory viruses lacking NS2 protein can be destroyed by the body's immune response

Direct effect of SARS-CoV-2 on the kidney

UniSA scientists make a surprising discovery in the origins of antibiotic-resistant gene

Researchers report isolation of potently neutralizing antibodies against highly transmissible SARS-CoV-2 variants

DPP4 protein: The connection between severe COVID-19 and diabetes

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo